Synzyme Technologies LLC Irvine, CA - 92618

Synzyme Technologies LLC is categorized under Commercial Medical Research in Irvine, CA and active since 1992.

Synzyme Technologies LLC was established in 1992, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417112 by the NAICS.

If you are seeking more information, feel free to contact Carleton Hsia, Chief Executive Officer at the company’s single location by writing to 1 Technology Drive # B115, Irvine, California CA 92618 or by phoning (949) 453-1073. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Synzyme Technologies LLC
Contact Person: Carleton Hsia, Chief Executive Officer
Address: 1 Technology Drive # B115, Irvine, California 92618
Phone Number: (949) 453-1073
Website Address: synzyme.com
Annual Revenue (USD): Unknown
Founded: 1992
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 5417112
Share This Business:

Synzyme Technologies LLC was started in 1992 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Carleton Hsia, Chief Executive Officer for inquiries that concern Synzyme Technologies LLC by calling the company number (949) 453-1073, as your correspondence is most welcome. Additionally, the physical location of the single location of Synzyme Technologies LLC can be found at the coordinates 33.654967,-117.7397 as well as the street address 1 Technology Drive # B115 in Irvine, California 92618.

For its online presence, you may visit Synzyme Technologies LLC’s website at synzyme.com and engage with its social media outlets through on Twitter and on Facebook.